Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.
about
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic reviewBridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practiceAntipsychotic Polypharmacy and Corrected QT Interval: A Systematic ReviewPrevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatmentCurrent Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewOff-label use of sodium valproate for schizophreniaExtracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.New roles for pharmacists in community mental health care: a narrative review.Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences.Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapyTreatment resistant schizophrenia: a comprehensive survey of randomised controlled trials.Medication-free Alternatives for Long-term Maintenance of Bipolar Disorder: A Case Series.A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.Validation of a claims-based antipsychotic polypharmacy measureMetabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.Safety and tolerability of antipsychotic polypharmacy.An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar DisorderAntipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year ComparisonA Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance ProgramAntipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practicePredictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare.Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria.Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysisHousing First Improves Adherence to Antipsychotic Medication Among Formerly Homeless Adults With Schizophrenia: Results of a Randomized Controlled Trial.Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness.A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order.Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management.Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective.Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.Comparison of treatment selections by Japanese and US psychiatrists for major depressive disorder: A case vignette study.Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial.A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone.Antipsychotic combinations for schizophrenia.Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.Quality of life and functioning in first-episode psychosis Chinese patients with different antipsychotic medications.
P2860
Q26751363-44A698A2-D562-4E4B-BF2A-A8C01C5D6BBBQ26800235-6F12FCB6-5DCA-4B79-BD5F-E7E3BCE7D18DQ26801835-9CAD5652-66CD-475C-85EE-E510516E63CBQ27028197-3892C3A8-CEE6-4BC1-AA32-1436D67D0BE1Q28079821-685E5DDF-357E-4072-8623-5019DF342FE3Q28541404-B8C595F8-9390-426C-8AD1-4D077368E040Q30981989-B90E2947-9738-443E-B81D-52A35851B444Q33560808-B075B627-4D60-4E2F-B1DE-3DC7CA7C8B71Q34194447-3EC1C247-C076-4F32-93F4-B2B214A3E462Q34412191-674BD16F-AFBF-496C-BB45-760F46F20C5CQ34491836-B7228A1B-53C9-4E95-9EEA-122F8294D83FQ34523396-1438F90C-66EA-4BD5-9336-C951A82FE4D9Q34686544-23BC63C4-F71A-4CAB-B374-206FF8F95BCBQ35256929-E7415E34-90FB-4F78-B719-B602C6677F34Q35585186-48E89C28-CC7F-4FC9-A922-E948EC49CC53Q35795401-4272EBA7-174B-4BC8-A7C7-83B06E5C4C9BQ35801221-BE1DABF4-95D2-40C3-934F-7E8B8A7187EDQ35925059-23875501-6508-435F-A9DD-59C827AC3708Q36062421-4AC74175-B177-42A0-B609-39DA4D0CD858Q36225284-85A38D70-BDC3-47C8-BE87-4ABD3D18A296Q36325431-321B68E7-AB44-4352-A20C-A6CB51B6CD97Q36852406-9F1AF950-84D4-4871-92B0-2417B9A9370DQ36852416-BA09AF4E-52B0-4328-9233-B5E18B9843CAQ37029622-ED7B830E-4566-4A44-9BDD-A01DC267C5BCQ37042072-CDA3CC69-4FE4-4F3A-BB25-7D8CF7342CA9Q37216848-F8D18ED0-75DE-4604-9234-02450FB52FFCQ37582708-C3226FEE-05D7-4CDE-9ADE-8806FA6D5084Q37609168-49976E15-940B-42F2-9D8F-837CF7C7D597Q37611162-4C7EFEA7-1795-4103-87B5-65E32A72F1FAQ38081872-5C492DEE-CB45-495B-9C6C-1642B48BAFF1Q38174188-826C5CDE-FCBC-4FFB-8FB6-583B327861E5Q38197159-97BDB32F-BD60-444E-B414-83EDEB05572EQ38203063-D4749299-F535-4D8A-A7B1-ED95038DC57BQ38239613-A0140194-C0BB-460E-A290-0255790AD171Q38324075-AD81ADA2-CEBA-47B7-8CFA-50A4EE285242Q38625817-5ED2BB64-2760-4DFC-820D-91F7AA760D77Q38682742-0E6BC48F-B775-4259-A09F-EAA253337CCEQ38704394-DCA84280-6203-4F99-A8E2-B9BB2AA2283EQ38769838-2D4DE8E6-361F-4869-B768-E033347F0E00Q38809849-213992C1-817B-4810-A282-C9EA64EF929C
P2860
Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prevalence and correlates of a ...... trends from the 1970s to 2009.
@ast
Prevalence and correlates of a ...... trends from the 1970s to 2009.
@en
type
label
Prevalence and correlates of a ...... trends from the 1970s to 2009.
@ast
Prevalence and correlates of a ...... trends from the 1970s to 2009.
@en
prefLabel
Prevalence and correlates of a ...... trends from the 1970s to 2009.
@ast
Prevalence and correlates of a ...... trends from the 1970s to 2009.
@en
P2093
P2860
P1476
Prevalence and correlates of a ...... trends from the 1970s to 2009.
@en
P2093
Christoph U Correll
John Bonetti
John M Kane
Juan A Gallego
P2860
P356
10.1016/J.SCHRES.2012.03.018
P407
P577
2012-04-24T00:00:00Z